During the past decade, Asst Papa Giovanni XXIII; Oncologia Medica conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asst Papa Giovanni XXIII; Oncologia Medica" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Asst Papa Giovanni XXIII; Oncologia Medica" are "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Malignant Melanoma" (2 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Asst Papa Giovanni XXIII; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Asst Papa Giovanni XXIII; Oncologia Medica" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Cisplatin" (5 trials), "Docetaxel" (4 trials), "Pertuzumab" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Asst Papa Giovanni XXIII; Oncologia Medica" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Asst Papa Giovanni XXIII; Oncologia Medica". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Asst Papa Giovanni XXIII; Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asst Papa Giovanni XXIII; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".